These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 1541051)
1. Increased in vivo production of tumor necrosis factor after development of diabetes in nontreated, long-term diabetic BB rats. Tanaka S; Seino H; Satoh J; Fujii N; Rikiishi H; Zhu XP; Takahashi K; Sagara M; Nobunaga T; Toyota T Clin Immunol Immunopathol; 1992 Mar; 62(3):258-63. PubMed ID: 1541051 [TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor production is deficient in diabetes-prone BB rats and can be corrected by complete Freund's adjuvant: a possible immunoregulatory role of tumor necrosis factor in the prevention of diabetes. Lapchak PH; Guilbert LJ; Rabinovitch A Clin Immunol Immunopathol; 1992 Nov; 65(2):129-34. PubMed ID: 1395129 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of type 1 diabetes in BB rats with recombinant human tumor necrosis factor-alpha. Satoh J; Seino H; Shintani S; Tanaka S; Ohteki T; Masuda T; Nobunaga T; Toyota T J Immunol; 1990 Sep; 145(5):1395-9. PubMed ID: 2384663 [TBL] [Abstract][Full Text] [Related]
4. Prevention of type I diabetes with lymphotoxin in BB rats. Takahashi K; Satoh J; Seino H; Zhu XP; Sagara M; Masuda T; Toyota T Clin Immunol Immunopathol; 1993 Dec; 69(3):318-23. PubMed ID: 8242903 [TBL] [Abstract][Full Text] [Related]
5. Inhibition with N-acetylcysteine of enhanced production of tumor necrosis factor in streptozotocin-induced diabetic rats. Sagara M; Satoh J; Zhu XP; Takahashi K; Fukuzawa M; Muto G; Muto Y; Toyota T Clin Immunol Immunopathol; 1994 Jun; 71(3):333-7. PubMed ID: 8200134 [TBL] [Abstract][Full Text] [Related]
6. In vivo and in vitro evidence of altered nitric oxide metabolism in the spontaneously diabetic, insulin-dependent BB/Edinburgh rat. Lindsay RM; Peet RS; Wilkie GS; Rossiter SP; Smith W; Baird JD; Williams BC Br J Pharmacol; 1997 Jan; 120(1):1-6. PubMed ID: 9117082 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of autoimmune diabetes in NOD mice with serum from streptococcal preparation (OK-432)-injected mice. Seino H; Satoh J; Shintani S; Takahashi K; Zhu XP; Masuda T; Nobunaga T; Saito M; Terano Y; Toyota T Clin Exp Immunol; 1991 Dec; 86(3):413-8. PubMed ID: 1747949 [TBL] [Abstract][Full Text] [Related]
8. Glucose control and long-term survival in biobreeding/Worcester rats after intraperitoneal implantation of hydrophilic macrobeads containing porcine islets without immunosuppression. Jain K; Asina S; Yang H; Blount ED; Smith BH; Diehl CH; Rubin AL Transplantation; 1999 Dec; 68(11):1693-700. PubMed ID: 10609945 [TBL] [Abstract][Full Text] [Related]
9. Relationship between albumin and fructosamine concentration in diabetic and non-diabetic sera. Johnson RN; Metcalf PA; Baker JR Clin Chim Acta; 1987 Apr; 164(2):151-62. PubMed ID: 3594908 [TBL] [Abstract][Full Text] [Related]
10. Antibodies to ICA512/IA-2 in rodent models of IDDM. Myers MA; Laks MR; Feeney SJ; Mandel TE; Koulmanda M; Bone A; Barley J; Rowley MJ; Mackay IR J Autoimmun; 1998 Jun; 11(3):265-72. PubMed ID: 9693975 [TBL] [Abstract][Full Text] [Related]
11. Influence of serum protein levels on serum fructosamine levels. Oimomi M; Masuta S; Sakai M; Ohara T; Hata F; Baba S Jpn J Med; 1989; 28(3):312-5. PubMed ID: 2739139 [TBL] [Abstract][Full Text] [Related]
12. Relation of fructosamine to serum protein, albumin, and glucose concentrations in healthy and diabetic dogs. Kawamoto M; Kaneko JJ; Heusner AA; Feldman EC; Koizumi I Am J Vet Res; 1992 May; 53(5):851-5. PubMed ID: 1524315 [TBL] [Abstract][Full Text] [Related]
13. Diabetes mellitus induced inhibition of glucosaminyl N-deacetylase: effect of short-term blood glucose control in diabetic rats. Kofoed-Enevoldsen A; Noonan D; Deckert T Diabetologia; 1993 Apr; 36(4):310-5. PubMed ID: 8477875 [TBL] [Abstract][Full Text] [Related]
14. An early but intense cytokine production within the islets may be predictive for type 1 diabetes occurrence in the Bio Breeding (BB) rat. Papaccio G; Graziano A; d'Aquino R; De Francesco F; Puca A; Pedullà M J Cell Physiol; 2006 Dec; 209(3):1016-20. PubMed ID: 16972262 [TBL] [Abstract][Full Text] [Related]
15. Abnormal TNF-alpha production in diabetes-prone BB rats: enhanced TNF-alpha expression and defective PGE2 feedback inhibition. Rothe H; Ongören C; Martin S; Rösen P; Kolb H Immunology; 1994 Mar; 81(3):407-13. PubMed ID: 8206514 [TBL] [Abstract][Full Text] [Related]
16. Effect of nifedipine on glucose tolerance, serum insulin, and serum fructosamine in diabetic and nondiabetic patients. Gill JS; Al-Hussary N; Zezulka AV; Pasi KJ; Atkins TW; Beevers DG Clin Ther; 1987; 9(3):304-10. PubMed ID: 3300989 [TBL] [Abstract][Full Text] [Related]
17. Effect of octreotide and insulin on manifest renal and glomerular hypertrophy and urinary albumin excretion in long-term experimental diabetes in rats. Grønbaek H; Nielsen B; Osterby R; Harris A; Orskov H; Flyvbjerg A Diabetologia; 1995 Feb; 38(2):135-44. PubMed ID: 7536170 [TBL] [Abstract][Full Text] [Related]
18. Tumour necrosis factor-alpha plasma level in patients with type 1 diabetes mellitus and its association with glycaemic control and cardiovascular risk factors. Lechleitner M; Koch T; Herold M; Dzien A; Hoppichler F J Intern Med; 2000 Jul; 248(1):67-76. PubMed ID: 10947883 [TBL] [Abstract][Full Text] [Related]
19. Forebrain ischemia in diabetic and nondiabetic BB rats studied with 31P magnetic resonance spectroscopy. Sutherland GR; Peeling J; Sutherland E; Tyson R; Dai F; Kozlowski P; Saunders JK Diabetes; 1992 Oct; 41(10):1328-34. PubMed ID: 1397707 [TBL] [Abstract][Full Text] [Related]
20. Prediction of insulin dependent diabetes mellitus in non-obese diabetic mice by the endogeneous tumor necrosis factor-alpha level. Setoguchi J; Hashiramoto K; Nakano K; Kitagawa Y; Nakamura N; Kanatsuna T; Kondo M; Uno K Diabetes Res; 1992 Feb; 19(2):63-7. PubMed ID: 1286540 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]